Technical Analysis for PTCT - PTC Therapeutics, Inc.

Grade Last Price % Change Price Change
F 47.06 2.39% 1.10
PTCT closed down 0.76 percent on Wednesday, April 21, 2021, on 1.2 times normal volume.
Earnings due: Apr 28
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical PTCT trend table...

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 2.39%
BB Squeeze + Lower Band Touch Range Contraction 2.39%
BB Squeeze Started Range Contraction 2.39%
Down 3 Days in a Row Weakness 2.39%
Lower Bollinger Band Touch Weakness 2.39%
20 DMA Resistance Bearish -3.15%
Death Cross Bearish -3.15%
1,2,3 Retracement Bearish Bearish Swing Setup -3.15%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -3.15%
NR7 Range Contraction -3.15%
Older End-of-Day Signals for PTCT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above Previous Day's High about 2 hours ago
Outside Day about 2 hours ago
Up 2% about 2 hours ago
Up 1% about 4 hours ago
60 Minute Opening Range Breakout about 5 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

PTC Therapeutics, Inc. Description

PTC Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of orally administered and proprietary small-molecule drugs for patients living with serious and life-threatening conditions, including genetic and neuromuscular disorders, cancer, and infectious diseases. Its approach includes post-transcriptional control, RNA biology, and gene expression modulation by small-molecules. The company has strategic alliances with AstraZeneca; Celgene Corporation; Cystic Fibrosis Foundation; Genzyme Corporation; Gilead; Muscular Dystrophy Association; Merck & Co., Inc.; Parent Project Muscular Dystrophy; Pfizer Inc.; Roche; Spinal Muscular Atrophy Foundation; and Wellcome Trust. PTC Therapeutics, Inc. was founded in 1998 and is based in South Plainfield, New Jersey.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Biology Infectious Diseases Neurological Disorders Gene Expression Dystrophy Ptc Cystic Fibrosis Muscular Dystrophy Transcription Neurodegenerative Disorders Spinal Muscular Atrophy Genzyme Neuromuscular Disorders

Is PTCT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 70.82
52 Week Low 43.645
Average Volume 527,073
200-Day Moving Average 55.28
50-Day Moving Average 54.15
20-Day Moving Average 48.08
10-Day Moving Average 47.48
Average True Range 2.05
ADX 33.75
+DI 13.66
-DI 29.58
Chandelier Exit (Long, 3 ATRs ) 51.61
Chandelier Exit (Short, 3 ATRs ) 51.23
Upper Bollinger Band 50.22
Lower Bollinger Band 45.93
Percent B (%b) 0.01
BandWidth 8.94
MACD Line -2.12
MACD Signal Line -2.29
MACD Histogram 0.1715
Fundamentals Value
Market Cap 3.14 Billion
Num Shares 68.2 Million
EPS -4.10
Price-to-Earnings (P/E) Ratio -11.21
Price-to-Sales 11.48
Price-to-Book 8.55
PEG Ratio 0.81
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 48.84
Resistance 3 (R3) 48.86 47.93 48.36
Resistance 2 (R2) 47.93 47.19 47.92 48.20
Resistance 1 (R1) 46.94 46.74 46.48 46.92 48.04
Pivot Point 46.01 46.01 45.77 46.00 46.01
Support 1 (S1) 45.02 45.27 44.56 45.00 43.88
Support 2 (S2) 44.09 44.82 44.08 43.72
Support 3 (S3) 43.10 44.09 43.56
Support 4 (S4) 43.08